Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders

This book provides reviews on biomarker use in psychiatric and neurodegenerative diseases and the development of medications involved in their treatment, aiming to facilitate understanding and treatment and move into personalized medicine.

Format: Hardback
Length: 328 pages
Publication date: 21 February 2019
Publisher: Springer Nature Switzerland AG

This comprehensive book delves into the realm of biomarker utilization in the study of psychiatric and neurodegenerative diseases, as well as the development of medications for their treatment. It offers a comprehensive analysis of the various approaches employed in this research field, highlighting both their strengths and weaknesses. By thoroughly examining these shortcomings, the book aims to foster progress and facilitate a deeper understanding and effective treatment of these disorders.

The overarching disorders in question are highly complex, and their treatment requires a multidisciplinary approach. By integrating biomarker research with other areas of modern medicine, such as diabetes and heart disease, the book seeks to bridge the gap and provide a holistic approach to patient care.

The ultimate goal of this book is to advance the fields of psychiatry and neurodegenerative disorders toward personalized medicine. This approach involves tailoring treatment strategies to individual patients based on their unique genetic makeup, clinical characteristics, and disease progression. By leveraging valid biomarker tests and identifying novel drug targets, healthcare professionals can deliver the right medication at the right time, maximizing the chances of successful outcomes.

The development and application of valid biomarker tests are crucial in this pursuit. Biomarkers are measurable indicators of biological processes or disease states that can provide valuable insights into the underlying mechanisms of these disorders. By accurately identifying biomarkers, healthcare professionals can develop targeted therapies that specifically address the underlying causes of the disease, leading to more effective and personalized treatment.

Furthermore, the identification of novel drug targets is equally important. Novel drug targets are areas of the biological pathway that are believed to be involved in the development or progression of these disorders. By developing drugs that specifically target these targets, healthcare professionals can offer patients more effective and targeted treatment options, reducing the risk of side effects and improving patient outcomes.

In conclusion, this book serves as a valuable resource for healthcare professionals, researchers, and students interested in the field of biomarker utilization in psychiatry and neurodegenerative disorders. It provides a comprehensive analysis of the current state of the research, highlighting the successes and failures in this field. By fostering a deeper understanding of these disorders and leveraging novel drug targets, the book aims to advance the fields of personalized medicine and improve the lives of individuals affected by these debilitating conditions.

Weight: 674g
Dimension: 164 x 242 x 20 (mm)
ISBN-13: 9783030055417
Edition number: 1st ed. 2019